This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Stephen M. Hahn, M.D., Commissioner of Food and Drugs

Event Date: 07/21/2020
Location: Teleconference
Subject: Generic Drug User Fee Amendments Public Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government, industry, media and other registered guests

Event Date: 07/22/2020
Location: Virtual
Subject: Paley Media Council Program
FDA Participant/Group: COLIN ROM; ALEXANDER WOHL; JOHN WAGNER; SANDRA WALSH;
Non FDA Participant/Group: Media, industry, government and other registered participants

Event Date: 07/23/2020
Location: Virtual
Subject: Reauthorization of the Prescription Drug User Fee Act Public Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, government, media, academia and other registered guests

Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner

Event Date: 07/20/2020
Location: Virtual
Subject: Exploring Policy Options for Establishing Cannabidiol Safety Surveillance
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Patient groups, academia, other government, and industry

Event Date: 07/20/2020
Location: Virtual
Subject: Health Evolution Roundtable Forum on Next Generation IT In Health Care
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, and other stakeholders

Event Date: 07/22/2020
Location: Virtual
Subject: National Academy of Medicine Committee on Emerging Science, Technology, and Innovation in Health and Medicine (CESTI) Virtual Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Academics, patients, industry, other government, and other stakeholders

Event Date: 07/23/2020
Location: Virtual
Subject: Reagan-Udall Foundation: COVID-19 Evidence Accelerator Collaborative Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Patient groups, health care providers, industry, academia, and other stakeholders

Official Name: Anand Shah, M.D., Deputy Commissioner for Medical and Scientific Affairs

No Significant Event

Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 07/20/2020
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: NINA ZIMDAHL; LARRY MORRIS;
Non FDA Participant/Group: David Hatch, Jeff Massa, Jeff Swartz, Melody Ge, Yianni Papadopoulos (Corvium Inc.);

Event Date: 07/22/2020
Location: Virtual
Subject: Food Allergy Issues of Mutual Interest
FDA Participant/Group: Several FDA senior officials and staff
Non FDA Participant/Group: Anita Roach, Jason Linde, Lisa Gable, Sabine Levy, Steve Danon (Food Allergy Research & Education);

Event Date: 07/22/2020
Location: Virtual
Subject: Food Recall Processes
FDA Participant/Group: LARRY MORRIS; DONALD PRATER; SCOTT MACINTIRE; NINA ZIMDAHL; DOUGLAS STEARN; MARK MOORMAN; ANDREW KENNEDY; VINETTA HOWARD KING;
Non FDA Participant/Group: Roger Hancock (Recall InfoLink); Jim Flannery (Summit Ventures L.L.C);

Official Name: Lowell Schiller, Principal Associate Commissioner for Policy

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: John Wagner, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Acting Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

No Significant Event

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

Event Date: 07/23/2020
Location: Webex
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: N/A
Non FDA Participant/Group: Generic Animal Drug Alliance

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event